Duke Spinoff Cloud Pharmaceuticals Names Two Executives to Team

Drug discovery and development firm Cloud Pharmaceuticals named two new executives to its management team. New CFO Lyle Lohmeyer’s experience includes financial management positions at AAIPharma, Qualia Networks, and Energy Conversion Systems Holdings. Don Van Dyke joins as Cloud Pharmaceuticals’ COO after previously working as a consultant to the company. Research Triangle Park, NC-based Cloud Pharmaceuticals discovers and develops new drugs using proprietary technology originally developed at Duke University.

 

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.